Ang2 inhibitors and Tie2 activators: potential therapeutics in perioperative treatment of early stage cancer

por Khan, Kabir A, Wu, Florence TH, Cruz‐Munoz, William, Kerbel, Robert S
Publicado 2021

Metronomic chemotherapy offsets HIFα induction upon maximum‐tolerated dose in metastatic cancers

por Schito, Luana, Rey, Sergio, Xu, Ping, Man, Shan, Cruz‐Muñoz, William, Kerbel, Robert S
Publicado 2020

Suppressive impact of metronomic chemotherapy using UFT and/or cyclophosphamide on mediators of breast cancer dissemination and invasion

por Muñoz, Raquel, Hileeto, Denise, Cruz-Muñoz, William, Wood, Geoffrey A., Xu, Ping, Man, Shan, Viloria-Petit, Alicia, Kerbel, Robert S.
Publicado 2019

Immunostimulatory and anti-tumor metronomic cyclophosphamide regimens assessed in primary orthotopic and metastatic murine breast cancer

por Khan, Kabir A., Ponce de Léon, José L., Benguigui, Madeleine, Xu, Ping, Chow, Annabelle, Cruz-Muñoz, William, Man, Shan, Shaked, Yuval, Kerbel, Robert S.
Publicado 2020

Neoadjuvant antiangiogenic therapy reveals contrasts in primary and metastatic tumor efficacy

por Ebos, John ML, Mastri, Michalis, Lee, Christina R, Tracz, Amanda, Hudson, John M, Attwood, Kristopher, Cruz-Munoz, William R, Jedeszko, Christopher, Burns, Peter, Kerbel, Robert S
Publicado 2014